Print
Email
Print Edition StoriesMonday, November 16, 2009
Humedica forms scientific advisory board
By Mass High Tech staff
MHT's Galen Moore: Honoring innovation in New England
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
Health-care informatics firm Humedica has created a scientific advisory board reponsible for advising and guiding the Boston-based firm’s scientific and clinical direction.
Humedica’s scientific advisory board includes Paul Bleicher, chief medical officer at Humedica; John Halamka, CIO of Beth Israel Deaconess Medical Center and Harvard Medical School, and chair of the U.S. Healthcare Information Technology Standards Panel; Ashish Jha, of the Harvard School of Public Health, VA Boston Health Care System and Brigham and Women’s Hospital; Kenneth Kaitin, drug development expert; Isaac Kohane, director of the Children’s Hospital Boston Informatics Program and co-director of the Harvard Medical School’s Center for Biomedical Informatics; and David Nash, founding Dean of the Jefferson School of Population Health.
The 40-person company develops informatics products such as MinedShare, a platform that officials say enables clinical, operational and financial benchmarking and comparative analytics, and MinedStream, a near real-time predictive clinical surveillance system that officials say identifies high-risk, high-cost patients, tracks necessary care and supports clinicians as they intervene to improve care.
The company officially launched in September and closed a $30 million round of investment. It is backed by investments from venture capital firms Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners and boutique life sciences investment bank Leerink Swann.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.